These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 31727410

  • 1. Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial.
    Kroon FPB, Kortekaas MC, Boonen A, Böhringer S, Reijnierse M, Rosendaal FR, Riyazi N, Starmans M, Turkstra F, van Zeben J, Allaart CF, Kloppenburg M.
    Lancet; 2019 Nov 30; 394(10213):1993-2001. PubMed ID: 31727410
    [Abstract] [Full Text] [Related]

  • 2. Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial.
    Schett G, Bainbridge C, Berkowitz M, Davy K, Fernandes S, Griep E, Harrison S, Gupta A, Lloyd-Hughes J, Roberts A, Layton M, Nowak NA, Patel J, Rech J, Smith JE, Watts S, Tak PP.
    Lancet Rheumatol; 2020 Oct 30; 2(10):e623-e632. PubMed ID: 38273625
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, placebo-controlled trial of low-dose oral prednisolone for treating painful hand osteoarthritis.
    Wenham CY, Hensor EM, Grainger AJ, Hodgson R, Balamoody S, Doré CJ, Emery P, Conaghan PG.
    Rheumatology (Oxford); 2012 Dec 30; 51(12):2286-94. PubMed ID: 22956551
    [Abstract] [Full Text] [Related]

  • 4. Colchicine twice a day for hand osteoarthritis (COLOR): a double-blind, randomised, placebo-controlled trial.
    Døssing A, Henriksen M, Ellegaard K, Nielsen SM, Stamp LK, Müller FC, Kloppenburg M, Haugen IK, McCarthy GM, Conaghan PG, Ulff-Møller Dahl L, Terslev L, Altman RD, Becce F, Ginnerup-Nielsen E, Jensen L, Boesen M, Christensen R, Dal U, Bliddal H.
    Lancet Rheumatol; 2023 May 30; 5(5):e254-e262. PubMed ID: 38251589
    [Abstract] [Full Text] [Related]

  • 5. Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial.
    Ramanan AV, Quartier P, Okamoto N, Foeldvari I, Spindler A, Fingerhutová Š, Antón J, Wang Z, Meszaros G, Araújo J, Liao R, Keller S, Brunner HI, Ruperto N, JUVE-BASIS investigators, Paediatric Rheumatology International Trials Organisation.
    Lancet; 2023 Aug 12; 402(10401):555-570. PubMed ID: 37423231
    [Abstract] [Full Text] [Related]

  • 6. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.
    Villiger PM, Adler S, Kuchen S, Wermelinger F, Dan D, Fiege V, Bütikofer L, Seitz M, Reichenbach S.
    Lancet; 2016 May 07; 387(10031):1921-7. PubMed ID: 26952547
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.
    Aletaha D, Bingham CO, Tanaka Y, Agarwal P, Kurrasch R, Tak PP, Popik S.
    Lancet; 2017 Mar 25; 389(10075):1206-1217. PubMed ID: 28215362
    [Abstract] [Full Text] [Related]

  • 8. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial.
    van Velzen P, Ter Riet G, Bresser P, Baars JJ, van den Berg BTJ, van den Berg JWK, Brinkman P, Dagelet JWF, Daniels JMA, Groeneveld-Tjiong DRGL, Jonkers RE, van Kan C, Krouwels FH, Pool K, Rudolphus A, Sterk PJ, Prins JM.
    Lancet Respir Med; 2017 Jun 25; 5(6):492-499. PubMed ID: 28483402
    [Abstract] [Full Text] [Related]

  • 9. Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial.
    Howard J, Ataga KI, Brown RC, Achebe M, Nduba V, El-Beshlawy A, Hassab H, Agodoa I, Tonda M, Gray S, Lehrer-Graiwer J, Vichinsky E.
    Lancet Haematol; 2021 May 25; 8(5):e323-e333. PubMed ID: 33838113
    [Abstract] [Full Text] [Related]

  • 10. Hormone replacement therapy (conjugated oestrogens plus bazedoxifene) for post-menopausal women with symptomatic hand osteoarthritis: primary report from the HOPE-e randomised, placebo-controlled, feasibility study.
    Williams JAE, Chester-Jones M, Minns Lowe C, Goff MV, Francis A, Brewer G, Marian I, Morris SL, Warwick D, Eldridge L, Julier P, Gulati M, Barker KL, Barber VS, Black J, Woollacott S, Mackworth-Young C, Glover V, Lamb SE, Vincent TL, Vincent K, Dutton SJ, Watt FE.
    Lancet Rheumatol; 2022 Oct 25; 4(10):e725-e737. PubMed ID: 36341025
    [Abstract] [Full Text] [Related]

  • 11. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial.
    Krijbolder DI, Verstappen M, van Dijk BT, Dakkak YJ, Burgers LE, Boer AC, Park YJ, de Witt-Luth ME, Visser K, Kok MR, Molenaar ETH, de Jong PHP, Böhringer S, Huizinga TWJ, Allaart CF, Niemantsverdriet E, van der Helm-van Mil AHM.
    Lancet; 2022 Jul 23; 400(10348):283-294. PubMed ID: 35871815
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate to treat hand osteoarthritis with synovitis (METHODS): an Australian, multisite, parallel-group, double-blind, randomised, placebo-controlled trial.
    Wang Y, Jones G, Keen HI, Hill CL, Wluka AE, Kasza J, Teichtahl AJ, Antony B, O'Sullivan R, Cicuttini FM.
    Lancet; 2023 Nov 11; 402(10414):1764-1772. PubMed ID: 37839420
    [Abstract] [Full Text] [Related]

  • 13. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial.
    Kloppenburg M, Ramonda R, Bobacz K, Kwok WY, Elewaut D, Huizinga TWJ, Kroon FPB, Punzi L, Smolen JS, Vander Cruyssen B, Wolterbeek R, Verbruggen G, Wittoek R.
    Ann Rheum Dis; 2018 Dec 11; 77(12):1757-1764. PubMed ID: 30282670
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme.
    Bugarski-Kirola D, Iwata N, Sameljak S, Reid C, Blaettler T, Millar L, Marques TR, Garibaldi G, Kapur S.
    Lancet Psychiatry; 2016 Dec 11; 3(12):1115-1128. PubMed ID: 27816567
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial.
    Venhoff N, Schmidt WA, Bergner R, Rech J, Unger L, Tony HP, Finzel S, Andreica I, Kofler DM, Weiner SM, Lamprecht P, Schulze-Koops H, App C, Pournara E, Mendelson MH, Sieder C, Maricos M, Thiel J.
    Lancet Rheumatol; 2023 Jun 11; 5(6):e341-e350. PubMed ID: 38251601
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial.
    Genovese MC, Fleischmann R, Combe B, Hall S, Rubbert-Roth A, Zhang Y, Zhou Y, Mohamed MF, Meerwein S, Pangan AL.
    Lancet; 2018 Jun 23; 391(10139):2513-2524. PubMed ID: 29908670
    [Abstract] [Full Text] [Related]

  • 17. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis - the HUMOR trial.
    Aitken D, Laslett LL, Pan F, Haugen IK, Otahal P, Bellamy N, Bird P, Jones G.
    Osteoarthritis Cartilage; 2018 Jul 23; 26(7):880-887. PubMed ID: 29499287
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy of low-dose radiation therapy on symptoms in patients with knee and hand osteoarthritis: follow-up results of two parallel randomised, sham-controlled trials.
    van den Ende CHM, Minten MJM, Leseman-Hoogenboom MM, van den Hoogen FHJ, den Broeder AA, Mahler EAM, Poortmans PMP.
    Lancet Rheumatol; 2020 Jan 23; 2(1):e42-e49. PubMed ID: 38258275
    [Abstract] [Full Text] [Related]

  • 19. Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Behr J, Bendstrup E, Crestani B, Günther A, Olschewski H, Sköld CM, Wells A, Wuyts W, Koschel D, Kreuter M, Wallaert B, Lin CY, Beck J, Albera C.
    Lancet Respir Med; 2016 Jun 23; 4(6):445-53. PubMed ID: 27161257
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
    Ahrén B, Masmiquel L, Kumar H, Sargin M, Karsbøl JD, Jacobsen SH, Chow F.
    Lancet Diabetes Endocrinol; 2017 May 23; 5(5):341-354. PubMed ID: 28385659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.